Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


June 02, 2015 3:01 PM ET

Healthcare Equipment and Supplies

Company Overview of Cordis Corporation

Company Overview

Cordis Corporation, through its subsidiaries, develops, manufactures, and distributes drug-eluting stents, catheters, and guide wires for interventional medicine, minimally invasive computer-based imaging, and electrophysiology applications. The company offers a portfolio of access, diagnostic, and interventional medical products for use in cardiovascular, endovascular, and biliary duct (liver) obstructive interventional procedures. Its cardiology products include transradial solutions for radial access procedures; diagnostic products, such as access kits, sheath introducers, diagnostic guide wires, and diagnostic catheters; guiding and PTCA dilatation catheters; and steerable guide wires an...

6500 Paseo Padre Parkway

Fremont, CA 94555

United States

Founded in 1959

3,620 Employees

Phone:

800-447-7585

Key Executives for Cordis Corporation

Vice President of Worldwide Clinical Research & Operations
Chief Scientific Officer and Global Head of Research & Development
Age: 53
Vice President of Regulatory Affairs and Quality Assurance
Age: 66
Vice President of Latin American Operations
Age: 85
Vice President of Corporate Relations and Assistant Secretary
Age: 77
Compensation as of Fiscal Year 2014.

Cordis Corporation Key Developments

Cardinal Health, Inc., Cordis Corporation - M&A Call

Cardinal Health, Inc., Cordis Corporation - M&A Call

LifeScreen Sciences LLC Enters into Settlement and Patent License Agreement with Cordis Corporation

Acacia Research Corporation announced that its subsidiary, LifeScreen Sciences LLC, has entered into a settlement and patent license agreement with Cordis Corporation. Reportedly, this agreement resolves litigation that was pending in the US District Court for the Eastern District of Texas.

LifeScreen Sciences LLC Enters into Settlement and Patent License Agreement with Cordis Corporation

Acacia Research Corporation announced that its LifeScreen Sciences LLC subsidiary has entered into a settlement and patent license agreement with Cordis Corporation. The agreement resolves litigation that was pending in the United States District Court for the Eastern District of Texas.

Similar Private Companies By Industry

Company Name Region
Bio Med Sciences, Inc. United States
Memtec Corporation United States
CareFusion 202, Inc. United States
Conor Medsystems, LLC United States
Aesthetic and Reconstructive Technologies, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cordis Corporation, please visit www.cordis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.